WaveMan
WaveMan · Company
CCRN · Cross Country Healthcare Inc
> Search tickers & screens ⌘K
LIVE
← All companies

CCRN Cross Country Healthcare (CCRN) Insider Trading, Ownership & Congress Trades

Services · Services-help supply services · CIK 0001141103
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
74
13F, latest reported quarter

Cross Country Healthcare insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for CROSS COUNTRY HEALTHCARE INC in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Chief Human Resources Officer
SELL
2026-03-12 SECtraded 2026-03-11
6,200
$60.1K
n/a
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Feb 23, 2024.
  • The trade is 22.1% of the 28,060 shares held after it.
  • No other insider sold within 30 days.
  • 74 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Human Resources Officer McDonald Colin Patrick sold about $60.1K of CCRN on Mar 11, 2026, the largest insider sale at the company since 2024; 74 funds added in the latest 13F quarter.
Director
BUY
2025-12-09 SEC
200
$1.6K
n/a
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Aug 30, 2022.
  • +0.0% median (+0.0% mean) 90-day return after 3 previous buys.
  • The trade is 0.1% of the 199,832 shares held after it.
  • No other insider bought within 30 days.
  • 74 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director CASH W LARRY bought about $1.6K of CCRN on Dec 9, 2025, the largest insider purchase at the company since 2022; 74 funds added in the latest 13F quarter.
Director
BUY
2025-12-09 SEC
4,800
$39.2K
n/a
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Aug 30, 2022.
  • +0.0% median (+0.0% mean) 90-day return after 3 previous buys.
  • The trade is 2.3% of the 204,632 shares held after it.
  • No other insider bought within 30 days.
  • 74 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director CASH W LARRY bought about $39.2K of CCRN on Dec 9, 2025, the largest insider purchase at the company since 2022; 74 funds added in the latest 13F quarter.
VP, Corporate Treasurer
SELL
2024-08-05 SECtraded 2024-08-02
1,945
$33.5K
n/a
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Nov 28, 2023.
  • The trade is 25.6% of the 7,605 shares held after it.
  • 1 other insider sold within 30 days.
  • 74 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: VP, Corporate Treasurer Grieco Cynthia Ann sold about $33.5K of CCRN on Aug 2, 2024; 1 other insider sold within 30 days and 74 funds added in the latest 13F quarter.
Pres., Cross Country Locums
SELL
2024-08-05 SECtraded 2024-08-02
13,829
$236.2K
n/a
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Mar 15, 2024.
  • The trade is 56.0% of the 24,696 shares held after it.
  • 1 other insider sold within 30 days.
  • 74 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Pres., Cross Country Locums Mote Karen sold about $236.2K of CCRN on Aug 2, 2024; 1 other insider sold within 30 days and 74 funds added in the latest 13F quarter.
38 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Showing the latest few. to see 33 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
74 funds bought in last quarter
below 55% of Services
Revenue
-21.6% year over year
below 89% of Services
Margin
-9.0% net margin
below 74% of Services
Buybacks
$5.9M repurchased, FY to 2026-03-31
below 78% of Services
Short interest
no short interest reported
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch CCRN

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

Who owns CCRN: institutional holders (13F)

13F holdings, latest reported quarter
2,750,102 sh
$36.3M
1,292,260 sh
$17.1M

Congress trades in CCRN

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

CCRN planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

CCRN mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Comstock Capital Value Fund
$118.9K position · as of 2026-06-30
1.1%
Boston Partners Long/Short Equity Fund
$956.0K position · as of 2026-05-31
0.8%
1290 VT GAMCO Mergers & Acquisitions Portfolio
$1.1M position · as of 2026-06-30
0.6%
The Gabelli ABC Fund
$2.6M position · as of 2026-06-30
0.6%
Enterprise Mergers and Acquisitions Fund
$363.3K position · as of 2026-06-30
0.6%
AltShares Merger Arbitrage ETF
$613.3K position · as of 2026-05-31
0.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 74 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Same sector, ranked by filing activity
Sector by SEC SIC code

CCRN financials

Revenue growth
-21.6%
XBRL, annual
Net margin
-9.0%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.0B
four quarters, 2025-04-01 to 2026-03-31
Net margin, TTM
-9.8%
net income over revenue, 2025-04-01 to 2026-03-31
Free cash flow, TTM
$39.6M
operating cash flow minus capex, 2025-04-01 to 2026-03-31
Debt to equity
0.00x
long-term 2023-12-31 (27 months older than the period end) plus current 2022-12-31 (39 months older than the period end); equity 2026-03-31
Cash flow to debt
n/a
no debt to cover
Return on equity
-27.0%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on assets
-19.2%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
-21.2%
operating income (EBIT proxy) over average of 2025-03-31 and 2026-03-31 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$322.8M
market value at close 2026-07-28 on 2026-04-24 shares, plus long-term 2023-12-31 (27 months older than the period end) plus current 2022-12-31 (39 months older than the period end), minus cash 2026-03-31
FCF yield
+9.2%
TTM free cash flow over market value at close 2026-07-28
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-07-28. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$1.1B$1.3B$2.0B$2.8B
Operating income-$84.4M-$16.9M$112.7M$269.9M
Net income-$94.9M-$14.6M$72.6M$188.5M
EPS (diluted)-2.93-0.442.054.95
Operating cash flow$48.3M$120.1M$248.5M$134.1M
Cash$108.7M$81.6M$17.1M$3.6M
Long-term debtn/an/a$0$150.7M
Buybacks$6.8M$37.3M$57.7M$35.3M
SEC XBRL, fiscal years, as known on 2026-10-28

CCRN Stock Sonar score 5/7 axes

Find similar shapesCompare

CCRN ranks highest on financial health (99th percentile) and institutional and government (29th), and lowest on growth (11th), among Services peers.

ProfitHealthGrowthInstitutionsRisk
Profitability
22
Inputs
  • Return on equity-27.0% · 21 pct, sector of 207
  • Return on assets-19.2% · 26 pct, sector of 269
  • Return on invested capitalpre-tax loss, no effective tax rate to apply
  • Return on capital employed-21.2% · 19 pct, sector of 203
Financial health
100
Inputs
  • Debt to equity0.00x · 100 pct, sector of 228
  • Cash flow to debtno debt to cover
Growth
11
Inputs
  • Revenue growth, YoY-21.6% · 11 pct, sector of 341
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
29
Inputs
  • Funds adding, latest quarter74 · 45 pct, sector of 243
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quarters$80K · 12 pct, sector of 61
Risk and compliance
17
Inputs
  • Short interest, % of floatno short interest or no free float on file
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+22.1% · 17 pct, sector of 227
2 not measured: Insider conviction, US patents
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing